---
title: "SEIDENBERG BETH C — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4e079dba-4a8d-566d-af6a-4bf35e8ca03d
json: https://whiteintel.dev/api/public/dossier/4e079dba-4a8d-566d-af6a-4bf35e8ca03d
identifier: sec:0001184592
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SEIDENBERG BETH C

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001184592`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/4e079dba-4a8d-566d-af6a-4bf35e8ca03d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4e079dba-4a8d-566d-af6a-4bf35e8ca03d  

## Ownership & control

### Holdings / subsidiaries

- **Kyverna Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/f0d67aac-4707-507f-88b3-33747c372407
- **Sagimet Biosciences Inc.** (director) — https://whiteintel.dev/entity/59ec54b9-20e1-5f14-bfc5-1d8a934dc068
- **Vera Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/fe80b53a-7dca-5ddd-b38a-dd53db7882ef
- **ACELYRIN, Inc.** (director) — https://whiteintel.dev/entity/c6f49748-e2c3-5631-8a94-6709729e393b
- **Kyverna Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/f0d67aac-4707-507f-88b3-33747c372407
- **Progyny, Inc.** (director) — https://whiteintel.dev/entity/d51ba398-6830-5312-a12a-668000ba70e1
- **ACELYRIN, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/c6f49748-e2c3-5631-8a94-6709729e393b
- **Atara Biotherapeutics, Inc.** (director) — https://whiteintel.dev/entity/8a5507e4-9c1c-5edd-82c9-7075a400f0ab
- **EPIZYME, INC.** (director) — https://whiteintel.dev/entity/1962d800-cae3-56fc-a964-5bee0a4135a8
- **TESARO, INC.** (director) — https://whiteintel.dev/entity/266e6228-4a9a-5988-80b0-745c392c3240
- **ARMO BIOSCIENCES, INC.** (director) — https://whiteintel.dev/entity/43b85de3-691c-5ab6-bbac-89086a2cdae3
- **ARMO BIOSCIENCES, INC.** (tenpercentowner) — https://whiteintel.dev/entity/43b85de3-691c-5ab6-bbac-89086a2cdae3
- **EPIZYME, INC.** (tenpercentowner) — https://whiteintel.dev/entity/1962d800-cae3-56fc-a964-5bee0a4135a8
- **Atara Biotherapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/8a5507e4-9c1c-5edd-82c9-7075a400f0ab
- **BIOCRYST PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/4c2abb17-afd7-5282-930a-5a120a05fb83

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SEIDENBERG BETH C**. Human view: https://whiteintel.dev/entity/4e079dba-4a8d-566d-af6a-4bf35e8ca03d · Structured JSON: https://whiteintel.dev/api/public/dossier/4e079dba-4a8d-566d-af6a-4bf35e8ca03d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._